Infection with the Human Immunodeficiency Virus (HIV) is a public health threat whose significance in the UK has only been generally appreciated over the last 12–18 months. The size of the problem (both current and potential) is difficult to assess, but epidemiological data would suggest that for an urban health district (outside London) one or two residents would have developed Acquired Immune Deficiency Syndrome (AIDS) in 1986, four will do so in 1987 and six in 1988. The incidence of HIV infections during the same period might be as high as 200, 400 and 600 respectively. This may seem a small number in comparison with overall morbidity and mortality; but between September 1990 and June 1991 the same health district might expect 48 AIDS cases to present if the epidemiological patterns remain constant (ie a doubling time for cases of 10 months).
Article navigation
1 January 1987
This article was originally published in
Journal of Management in Medicine
Review Article|
January 01 1987
Approaches to the control of AIDS within the community
D. Baxter
D. Baxter
Lecturer in Community Medicine at Manchester University Medical School
Search for other works by this author on:
Publisher: Emerald Publishing
Online ISSN: 1758-7441
Print ISSN: 0268-9235
© MCB UP Limited
1987
J Manag Med (1987) 2 (1): 7–26.
Citation
Baxter D (1987), "Approaches to the control of AIDS within the community". J Manag Med, Vol. 2 No. 1 pp. 7–26, doi: https://doi.org/10.1108/eb060457
Download citation file:
140
Views
New and popular articles
Suggested Reading
AIDS IN THE WORKPLACE
International Journal of Manpower (June,1988)
Blood-borne viral co-infections among human immunodeficiency virus-infected inmates
Int J Prison Health (June,2016)
U.S. GOVERNMENT DOCUMENTS, EXECUTIV BRANCH, ON AIDS, 1986–1989
Collection Building (January,1991)
Selected CDC HIV/AIDS information resources
Reference Services Review (February,1991)
Conclusion: U.S. Government Documents, Executive Branch, on AIDS, 1986–1989
Collection Building (March,1991)
Related Chapters
Estimating the social and economic benefits of pharmaceutical innovation: modeling clinical trial results in hiv disease
Investing in Health: The Social and Economic Benefits of Health Care Innovation
Estimating economic cost of HIV/AIDS-related diseases
Investing in Health: The Social and Economic Benefits of Health Care Innovation
Impacts of the COVID-19 Response on Populations with Chronic Conditions and Developmental Disabilities
COVID-19, Frontline Responders and Mental Health: A Playbook for Delivering Resilient Public Health Systems Post-Pandemic
Recommended for you
These recommendations are informed by your reading behaviors and indicated interests.
